Diagnostic utility of weight and body mass index is widely overestimated, and their use as health and wellness measures can be sources of iatrogenic harm.
AMA J Ethics. 2023;25(7):E540-544. doi:
10.1001/amajethics.2023.540.
AMA Journal of Ethics theme editor James Aluri, a third-year medical student at Johns Hopkins University, interviewed Dr. Autumn Fiester, PhD, about strategies for defusing “difficult” patient-clinician relationships.
The adverse health effects of climate change should be the focus of physician advocacy efforts and of conversations between physicians and their patients.
AMA J Ethics. 2017;19(12):1174-1182. doi:
10.1001/journalofethics.2017.19.12.ecas3-1712.
One of the many doors money and power often open gives access to opioids where they would otherwise be withheld without strict oversight and management. Elvis Presley provides perhaps the most famous example of unmanaged access to drugs.
The question of whether and how results from personal genetic testing will motivate behavioral changes in consumers has only begun to receive the research attention it richly deserves.
Kyle B. Brothers, MD, PhD and Esther E. Knapp, MD, MBE
Direct-to-consumer genetic testing requires that physicians share decision making with patients, not order unnecessary tests or interventions, and refer to genetic specialists when necessary.
AMA J Ethics. 2018;20(9):E812-818. doi:
10.1001/amajethics.2018.812.